Fiber-Fed mice show promise against prostate cancer
NCT ID NCT06661044
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed study from the University of Aberdeen looked at how dietary fiber supplements might influence prostate cancer. Researchers gave mice different fibers (inulin, pectin, hemp hull) along with stool samples from healthy men over 60. They then measured changes in gut bacteria and tumor growth. Only 6 volunteers provided samples, and the work was done in mice, not people.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- dietary fiber supplements (inulin, pectin, hemp hull)
- What this could lead to
- If successful, this could point toward dietary fiber as a simple nutritional therapy to help manage prostate cancer.
- What could go wrong
- This is a very small, early-stage study in mice, not humans. Results may not translate to people, and the effect on tumors is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Aberdeen
Aberdeen, Scotland, AB25 2ZD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Virtual cooking classes aim to boost health for hispanic prostate cancer survivors and their families
- Prostate Surgery's hidden toll: study probes lasting impact on Men's lives
- Which gas pump causes less pain during robotic prostate surgery? a Head-to-Head trial
- Nerve-Sparing radiation may help men keep sexual function after prostate cancer treatment
- New genetic test may predict prostate cancer drug response before surgery
- Powder during prostate surgery may cut bleeding and save sexual function